Cargando…
The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D(3) Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer
Active vitamin D(3), 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], and its synthetically derived analogs possess potent anticancer properties. In breast cancer (BC) cells, 1,25(OH)(2)D(3) blocks cell proliferation and induces apoptosis through different cell-type specific mechanisms. In this study,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248359/ https://www.ncbi.nlm.nih.gov/pubmed/35784555 http://dx.doi.org/10.3389/fendo.2022.886238 |